Navigation Links
Cardiva Medical, Inc. Completes $15.5 Million Private Equity Financing
Date:5/5/2008

MOUNTAIN VIEW, Calif., May 5 /PRNewswire/ -- Cardiva Medical, Inc., a privately held medical device company, announced today it has closed a $15.5 million private equity financing lead by PTV Sciences. Also investing in this financing were existing investors Galen Partners, Sycamore Ventures, Amkey Ventures, Lexli Investment, and Eminent Venture Capital. Cardiva intends to use the proceeds of the financing for general corporate purposes, including the expansion of its U.S. sales force.

Cardiva also announced that Mr. Rick Anderson, a Managing Director with PTV Sciences will join Cardiva's Board of Directors. Prior to PTV Sciences, Mr. Anderson served as Company Group Chairman, Johnson & Johnson, and Worldwide Franchise Chairman, Cordis Corporation. He was a key architect behind the launch of the world's first drug-eluting stent the CYPHER(R) Sirolimus-eluting Coronary Stent.

"We are delighted that PTV Sciences has joined with Cardiva's current investors to finance the expansion of our direct sales force in the U.S.," said Augustine Lien, Chairman and CEO. "We now have the resources to aggressively expand our customer base. We are also extremely pleased that Rick Anderson is joining our Board of Directors as his experience is ideally suited to assist Cardiva's expansion in the U.S. cardiology market."

"We are extremely excited about Cardiva's growth prospects," commented Rick Anderson. "Cardiva represents an outstanding opportunity to improve patient care by allowing patients to be discharged from the hospital faster without the complications usually associated with vascular closure devices, especially in interventional cardiology."

About Cardiva Medical, Inc.

Founded in July 2002, and headquartered in Mountain View, Calif., Cardiva Medical, Inc. is a privately held medical device company focused on developing and commercializing devices which close the vascular access site with unsurpassed safety and ease-of-use. Cardiva's f
'/>"/>

SOURCE Cardiva Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
2. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
3. Cardiva Medical, Inc. Appoints Two New Officers: Malcolm Farnsworth as Vice President of Finance and Chief Financial Officer and Tara Zerby as Vice President of Business Development and Marketing
4. Cardiva Medical, Inc. to Present Highlights of the Boomerang Catalyst(TM) II System at the Investment in Innovation (In3) West Conference on February 29, 2008 in Las Vegas, NV
5. Medical, technological advances prompt updating of nuclear medicine technologists scope of practice
6. Thermage, Inc. Announces Distribution Agreement With Eclipse Medical, Ltd.
7. Medical, Behavioral Woes Can Drive Dogs to Bite
8. ReBuilder Medical Technologies, Inc. Announces UK Demand for Safe Molluscum Contagiosum Treatment Leads to Distribution Agreement with UFFE Medical, LTD. Expected 10% Sales Increase.
9. Sedgwick CMS and UnitedHealth Group to Develop Integrated Disability, Medical, Workers Compensation and Leave Administration Services for Employers
10. Emmaus Medical, Inc. Enters Into Sub-License Agreement for Treatment of Short Bowel Syndrome
11. XCPT(TM) Patient Engagement and Communication Software Signs Representation Agreement with Lifecore Biomedical, Inc. (Nasdaq: LCBM)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ients who have a prostate-specific antigen (PSA) v...er external beam radiation therapy (EBRT) are less...ated death, according to a study in the December 1...ncology*Biology*Physics, the official journal of t...., PSA levels in a prostate cancer patient are m...
(Date:12/2/2009)...straint-induced movement therapy (CIMT) is a poten... with hemiplegic cerebral palsy, but more research...ublished in the November issue of Physical Therap...hysical Therapy Association (APTA). The review, wh...tic reviews, concluded that further research shoul...
(Date:12/2/2009)... AB First Aid has been a top name in the medic...ith quality products, professional staff, and a ke...s, AB First Aid has established itself as a provid..., and as a first aid supplies distributor. The dis...t to enter into its next phase with the redesign a...
(Date:12/2/2009)... National Race Series to increase awareness of...s on the importance of early detection , ...9 -- Men, women, families, friends and neighbors &...o participate in the Rudolph Ramble 5K. The Rudol...Series , which was launched by the Prostate Condi...
(Date:12/2/2009)... A team of Kendall Hunt authors earned the 200...t the recent National Association for Gifted Child...er 5-7, 2009. , Dubuque, ...unt authors earned the 2009 Gifted Child Quarterly...sociation for Gifted Children’s annual confe...
Breaking Medicine News(10 mins):Health News:PSA value at 2 years post-treatment can predict long-term survival in prostate cancer patients 2Health News:Report shows CIMT may improve arm use in children with hemiplegic cerebral palsy 2Health News:From A to B and Everything In-between; AB First Aid Launch New Web Storefront 2Health News:From A to B and Everything In-between; AB First Aid Launch New Web Storefront 3Health News:PACE Race Returns with Denver's Rudolph Ramble 2Health News:PACE Race Returns with Denver's Rudolph Ramble 3Health News:PACE Race Returns with Denver's Rudolph Ramble 4Health News:Kendall Hunt Authors Earn NAGC “Paper of the Year” Award 2
...a kidney transplant, severe and morbid obesity are...gan, reports a study in the February Journal of th...rry L. Segev of the Johns Hopkins University Schoo...splantation. "The results identify a potential bi...
...t The University of Texas Health Science Center at...n markers in human saliva to provide an early, non... a study published in the Jan. 10, 2008 issue of t...n glandular secretions from the salivary glands. ...
...anthropy, PITTSBURGH, Jan. 10 Bayer Corporation,...porate philanthropic arm,to Bayer USA Foundation (...ocused one of the Foundation,s four strategic givi...) portfolio. The rebranding and,refocusing of Baye...
... Public Health; Progress Needed,in Other Key Areas... very high and three very low grades in tobacco co...s State of Tobacco Control 2007 report, which,high...cess. Illinois received the following grades:, --...
...egetables are the ones you can,t ...10 The Yotta Bar(R),developed by two Michigan par...ar old to eat his vegetables, provides one full se...res for those,consumers needing to sneak extra ser...
...egenerative disorder called spinal muscular atroph...-- Ann Messer knew something was wrong while she w...didn,t move, except sometimes to roll over to one ...ne, he had contractures in his knee joints," Messe...
Other Medicine News:Health News:Extreme obesity affects chances of kidney transplantation 2Health News:UT Health Science Center researchers decoding saliva to detect breast cancer 2Health News:UT Health Science Center researchers decoding saliva to detect breast cancer 3Health News:Bayer Corporation Renames Its U.S. Foundation, Refocuses Charitable Giving Areas 2Health News:Bayer Corporation Renames Its U.S. Foundation, Refocuses Charitable Giving Areas 3Health News:American Lung Association Report Gives Illinois Mixed Grades 2Health News:American Lung Association Report Gives Illinois Mixed Grades 3Health News:Hidden Veggies on the go hits Whole Foods Market(R) in 2008 2Health News:Years-Long Search Unlocks Deadly Genetic Disease 2Health News:Years-Long Search Unlocks Deadly Genetic Disease 3Health News:Years-Long Search Unlocks Deadly Genetic Disease 4
(Date:12/1/2009)...Newswire-FirstCall/ -- drugstore.com, inc. (Nasdaq...auty, vision, and pharmacy products, today announc...omer orders were the highest in company history. T....com web stores featured more special offers than...n yet. ,, (Logo: http://www.newscom.com/cgi-bi...
(Date:12/1/2009).../ -- Reportlinker.com announces that a new market ..., Molecular Diagnostics - A World Market Review ...ular-Diagnostics---A-World-Market-Review.html ,... several growth factors that include the need for ...bine optimized sample preparation, analysis, and d...
(Date:12/1/2009)...e/ -- Reportlinker.com announces that a new market..., Direct to Consumer (DTC) Advertising in Pharm...gulatory Landscape and Case Studies ,, http:/...DTC-Advertising-in-Pharmaceuticals---Current-and-F...-Studies.html ,, Summary ,, The author ha...
Breaking Medicine Technology:drugstore.com, inc. Has Best Day Ever on Cyber Monday 2drugstore.com, inc. Has Best Day Ever on Cyber Monday 3Reportlinker Adds Molecular Diagnostics - A World Market Review 2Reportlinker Adds Molecular Diagnostics - A World Market Review 3Reportlinker Adds Molecular Diagnostics - A World Market Review 4Reportlinker Adds Molecular Diagnostics - A World Market Review 5Reportlinker Adds Molecular Diagnostics - A World Market Review 6Reportlinker Adds Molecular Diagnostics - A World Market Review 7Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 2Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 3Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 4Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 5Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 6Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 7Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 8Small nanoparticles bring big improvement to medical imaging 10784 1Small nanoparticles bring big improvement to medical imaging 10784 2NanoString Technologies announces research collaboration with the Broad Institute 10781 1NanoString Technologies announces research collaboration with the Broad Institute 10781 2Heart Failure Drug May Help More in Higher Doses 61609 1Heart Failure Drug May Help More in Higher Doses 61609 2
... Disease on Work Status and,Productivity, WASHINGT...s,presented today at Digestive Disease Week(R) 200...ls (Active Ulcerative Colitis 1,& 2) show that...ative colitis (UC) who had responded to REMICADE(R...maintained,improvement in their clinical symptoms ...
...y 23, 2007 - Synta,Pharmaceuticals Corp., (NASDAQ:...overing, developing, and commercializing small,mol...day announced,that survival and sub-population dat...elanoma of the Company,s lead oncology drug,candid...ting of the,American Society of Clinical Oncology ...
Other Medicine Technology:Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 2Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 3Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 4Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 5Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 6Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 7Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 8Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 9Synta Oncology Candidate STA-4783 Clinical Trial Results to Be,Presented at the ASCO Annual Meeting 2Synta Oncology Candidate STA-4783 Clinical Trial Results to Be,Presented at the ASCO Annual Meeting 3
Philips Follower Catheters
Finlayson Ureteral Access Set
Cook Enforcer Balloon Dilation Catheters
Ascend™ Ureteral Dilation Balloon Catheter
Medicine Products: